Literature DB >> 15527763

Action of solamargine on human lung cancer cells--enhancement of the susceptibility of cancer cells to TNFs.

Li-Feng Liu1, Chia-Hua Liang, Li-Yen Shiu, Wei-Ling Lin, Chih-Chao Lin, Kou-Wha Kuo.   

Abstract

Solamargine (SM), isolated from Solanum incanum herb, displayed a superior cytotoxicity in four human lung cancer cell lines. The half-inhibitory concentrations (IC50), of the cell viability assay for H441, H520, H661 and H69 cells were 3, 6.7, 7.2 and 5.8 microM, respectively. SM-induced apoptosis of these cells by PS externalization in a dose-dependent manner and increased sub-G1 fraction were observed. Quenching of the expression of tumor necrosis factor receptors (TNFRs) during the progress of human lung carcinogenesis has been previously reported. SM may induce cell apoptosis via modulating the expression of TNFRs and their subsequent TRADD/FADD signal cascades. Subsequently, SM treatment increased the binding activities of TNF-alpha and TNF-beta to the lung cancers, and the intrinsic TNFs-resistant cancer cells became susceptible to TNF-alpha and -beta. In addition, SM caused release of cytochrome c, downregulation of anti-apoptotic Bcl-2 and Bcl-xL, increase of caspase-3 activity, and DNA fragmentation. Thus, SM could modulate the expressions of TNFRs and Bcl-2, and might be a potential anticancer agent for TNFs and Bcl-2 related resistance of human lung cancer cells.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15527763     DOI: 10.1016/j.febslet.2004.09.064

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  17 in total

Review 1.  Chemistry of trisdecacyclic pyrazine antineoplastics: the cephalostatins and ritterazines.

Authors:  Seongmin Lee; Thomas G LaCour; Philip L Fuchs
Journal:  Chem Rev       Date:  2009-06       Impact factor: 60.622

2.  A natural compound, methyl angolensate, induces mitochondrial pathway of apoptosis in Daudi cells.

Authors:  Kishore K Chiruvella; Sathees C Raghavan
Journal:  Invest New Drugs       Date:  2010-02-20       Impact factor: 3.850

3.  Effect of solanine on the membrane potential of mitochondria in HepG2 cells and [Ca2+]i in the cells.

Authors:  Shi-Yong Gao; Qiu-Juan Wang; Yu-Bin Ji
Journal:  World J Gastroenterol       Date:  2006-06-07       Impact factor: 5.742

4.  Targeting signal transducer and activator of transcription 3 contributes to the solamargine-inhibited growth and -induced apoptosis of human lung cancer cells.

Authors:  Yan Zhou; Qing Tang; Shunyu Zhao; Fang Zhang; Liuning Li; WanYin Wu; ZhiYu Wang; Swei Hann
Journal:  Tumour Biol       Date:  2014-05-21

5.  Steroidal glycoalkaloids from Solanum nigrum target cytoskeletal proteins: an in silico analysis.

Authors:  Rumana Ahmad
Journal:  PeerJ       Date:  2019-01-03       Impact factor: 2.984

6.  Methyl angolensate from callus of Indian redwood induces cytotoxicity in human breast cancer cells.

Authors:  Kishore K Chiruvella; Kuppusamy Panjamurthy; Bibha Choudhary; Omana Joy; Sathees C Raghavan
Journal:  Int J Biomed Sci       Date:  2010-09

7.  Solanum Incanum Extract Downregulates Aldehyde Dehydrogenase 1-Mediated Stemness and Inhibits Tumor Formation in Ovarian Cancer Cells.

Authors:  Yi-Hui Wu; Wen-Tai Chiu; Ming-Jer Young; Tzu-Hao Chang; Yu-Fang Huang; Cheng-Yang Chou
Journal:  J Cancer       Date:  2015-08-22       Impact factor: 4.207

Review 8.  Roots and Tuber Crops as Functional Foods: A Review on Phytochemical Constituents and Their Potential Health Benefits.

Authors:  Anoma Chandrasekara; Thamilini Josheph Kumar
Journal:  Int J Food Sci       Date:  2016-04-03

9.  Solamargine triggers cellular necrosis selectively in different types of human melanoma cancer cells through extrinsic lysosomal mitochondrial death pathway.

Authors:  Sana S Al Sinani; Elsadig A Eltayeb; Brenda L Coomber; Sirin A Adham
Journal:  Cancer Cell Int       Date:  2016-02-17       Impact factor: 5.722

10.  Solanum incanum extract (SR-T100) induces melanoma cell apoptosis and inhibits established lung metastasis.

Authors:  Sebastian Yu; Hamm-Ming Sheu; Chih-Hung Lee
Journal:  Oncotarget       Date:  2017-10-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.